Achievements in CKD-MBD guidelines targets: Is there a progress in the implementation practice?

International Urology and Nephrology

Volumn 44, Issue 6, 2012, Pages 1791-1798

  Spasovski, G ^a   Zdravkovska, V ^b   Zabzun, M ^b   Antarorov, R ^c   Ivanovski, K ^b   Janakievska, P ^d   Neskovski, J ^b   Karceva Sarajlia, E ^b   Panova, B ^b   Petrovska, T ^b   Zulbeari, L ^b   Masin Spasovska, J ^a   Taleska Matovska, N ^b   Gelev, S ^a  

^a SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

^b Dialysis Unit   (Macedonia)

^c Military Hospital   (Macedonia)

^d Dialysis Unit   (Macedonia)

Author keywords

CKD MBD; Dialysis; Guidelines; Implementation; KDOQI

Indexed keywords

CALCITRIOL; CALCIUM; CALCIUM CARBONATE; PARATHYROID HORMONE; PHOSPHATE; MINERAL;

ADULT; ARTICLE; BONE DISEASE; BONE METABOLISM; BONE MINERAL; CALCIUM DIALYSATE LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIALYSATE LEVEL; DIALYSIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE REDUCTION; FEMALE; HUMAN; MACEDONIA (REPUBLIC); MAJOR CLINICAL STUDY; MALE; MINERAL DEFICIENCY; PRACTICE GUIDELINE; PUBLICATION; TREND STUDY; CHRONIC KIDNEY FAILURE; METABOLIC BONE DISEASE; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; UTILIZATION REVIEW;

BONE DISEASES, METABOLIC; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; MINERALS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES;

EID: 84877596575     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-011-0092-x     Document Type: Article

References (24)

1. Levin N, Eknoyan G, Pipp M, Steinberg E (1997) National Kidney Foundation: dialysis outcome quality initiative-development of methodology for clinical practice guidelines. Nephrol Dial Transplant 12:2060-2063
2. Moe S, Drueke T, Cunningham J, et al. (2006) Kidney disease: improving global outcomes (KDIGO). Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 69:1945-1953
3. Spasovski G, Massy Z, Vanholder R (2009) Phosphate metabolism in chronic kidney disease: from pathophysiology to clinical management. Semin Dial 22(4):357-362
4. Kestenbaum B, Sampson JN, Rudser KD, et al. (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16:520-528
5. Tentori F, Blayney MJ, Albert JM, et al. (2008) Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 52:519-530
6. National Kidney Foundation (2003) K/DOQI, NKF: clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1-S201
7. Zoccali C, Abramowicz D, Cannata-Andia JB, et al. (2008) European best practice quo vadis? From European best practice guidelines (EBPG) to European renal best practice (ERBP). Nephrol Dial Transplant 23:2162-2166
8. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 113:S1-S130
9. Goldsmith DJ, Covic A, Fouque D, Locatelli F, Olgaard K, Rodriguez M, Spasovski G, Urena P, Zoccali C, London GM, Vanholder R (2010) Endorsement of the kidney disease improving global outcomes (KDIGO) chronic kidney disease-mineral and bone disorder (CKD-MBD) guidelines: a European renal best practice (ERBP) commentary statement. Nephrol Dial Transplant 25(12):3823-3831
10. Spasovski G (2009) Treatment of hyperphosphataemia and relationship with the KDOQI CKD-MBD guidelines. Port J Nephrol Hypert 23(4):293-297. https://www.spnefro.pt/RPNH/PDFs/n4-2009/artigo-01.pdf
11. Spasovski G, Polenakovic M (2008) Renal best practice guidance/guidelines and implementation controversy. BANTAO J 6(2):1-2. http://www.bantao.org/6-2/6- 2-1.pdf
12. Spasovski G, Gelev S, Zdravkovska V, Tomanovski V, Trpenovski L, Ivanovski K, Bajraktarova T, Janakievska P, Damjanovski M, Neskovski J, Karceva-Sarajlia E, Petrovska T, Filkovska K, Matovic S, Luseva V, Jordanovski D, Zafirovska M (2005) Epidemiology of renal osteodystrophy in R. Macedonia. Bantao J 3(2):160-161. http://www.bantao.org/3-2/3-2-50.pdf
13. Stojceva-Taneva O (2010) Epidemiology of renal replacement therapy in Macedonia. Bosn J Basic Med Sci 10(Suppl 1):S23-S28
14. Spasovski G (2011) Can we decrease organ trafficking in the Balkans? Clin Transplant 25(3):E223-E224
15. Spasovski GB (2007) Bone health and vascular calcification relationships in chronic kidney disease. Int Urol Nephrol 39(4):1209-1216
16. London GM, Marty C, Marchais SJ, et al. (2004) Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15:1943-1951
17. Jean G, Lataillade D, Genet L, Legrand E, et al. (2011) Association between very low PTH levels and poor survival rates in haemodialysis patients: results from the French ARNOS cohort. Nephron Clin Pract 118(2):c211-c216
18. Spasovski G (2011) A review of Sevelamer hydrochloride in end-stage renal disease patients on dialysis. Clin Med Insights Ther 3:51-55. http://www.la-press.com/clinical-medicine-insights-Therapeutics-journal-j133
19. Spasovski G (2008) New strategies in treatment of mineral and bone disorders and associated cardiovascular disease in patients with chronic kidney disease. Recent Pat Cardiovasc Drug Discov 3(3):222-228
20. Spasovski G, Gelev S, Masin-Spasovska J, Selim G, Sikole A, Vanholder R (2007) Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium. Bone 41(4):698-703
21. Matias PJ, Jorge C, Ferreira C, et al. (2010) Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol 5:905-911
22. Wald R, Tentori F, Tighiouart H, Zager PG, Miskulin DC (2007) Impact of the kidney disease outcomes quality initiative (KDOQI) clinical practice guidelines for bone metabolism and disease in a large dialysis network. Am J Kidney Dis 49(2):257-266
23. Tangri N, Wagner M, Griffith JL, et al. (2011) Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom renal registry. Am J Kidney Dis 57(3):415-421
24. Arenas MD, Alvarez-Ude F, Gil MT, et al. (2006) Application of NKF-K/DOQI clinical practice guidelines for bone metabolism and disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units. Nephrol Dial Transplant 21:1663-1668